Sam Bankman-Fried isn't going down without a fight. The disgraced FTX founder on Tuesday pleaded not guilty on all counts, including multiple charges of fraud and conspiracy. 

Bankman-Fried, 30, is going a different route than his co-executives at FTX: Gary Wang, co-founder of FTX, and Caroline Ellison, CEO of Alameda Research, have both pleaded guilty. 

Indeed, there is widespread consensus that FTX's leadership engaged in criminal activity. Even current CEO John J. Ray III has described the situation as "old-fashioned embezzlement." 

The U.S. attorney of the Southern District of New York filed the charges in December, along with parallel actions from the Securities and Exchange Commission (SEC) and the Commodity Futures Trading Commission (CFTC).

Bankman-Fried is currently out of prison on a $250 million bail bond

Judge Lewis A. Kaplan has tentatively set a trial date of October 2nd. 

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More